Edges in Network
| Network | GSE16391_top500tf - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | ATF2 |
| Upstream (Parents) |
|---|
| (<<) ETS1 → ATF2 |
| (<<) AFF4 → ATF2 |
| (<<) FLI1 → ATF2 |
| (<<) HSF2 → ATF2 |
| (<<) ZNF192 → ATF2 |
| (<<) MAX → ATF2 |
| (<<) GABPA → ATF2 |
| (<<) CREB1 → ATF2 |
| (<<) ZNF131 → ATF2 |
| (<<) KDM5A → ATF2 |
| Downstream (Children) |
|---|
| ATF2 → HOXC9 (>>) |
| ATF2 → BTG2 (>>) |
| ATF2 → IRF6 (>>) |
| ATF2 → ZNF396 (>>) |
| ATF2 → TCEAL1 (>>) |
| ATF2 → ZNF83 (>>) |
| ATF2 → NANOG (>>) |
| ATF2 → CTNNB1 (>>) |
| ATF2 → GTF2H2 (>>) |
| ATF2 → SOX13 (>>) |
| ATF2 → ZNF500 (>>) |
| ATF2 → TFCP2 (>>) |
| ATF2 → GTF2I (>>) |
| ATF2 → ZRANB2 (>>) |
| ATF2 → ZNF140 (>>) |
| ATF2 → CBFB (>>) |
| ATF2 → ZFHX3 (>>) |
| ATF2 → NFYC (>>) |
| ATF2 → FOXJ3 (>>) |
| ATF2 → BRD8 (>>) |
| ATF2 → CREB3L2 (>>) |
